CPT12 Pressroom

DENVER – February 24, 2009 – How will new medical biotechnologies change the process of diagnosis, treatment and health care system efficiency? 

Those topics and more will be discussed with local experts and viewers during Studio 12 on Wednesday, Feb. 25 at 8 p.m. on Channel 12.

The program guests of host Steffan Tubbs will include Fred Mitchell, CEO of Beacon Biotechnology; David Howson, president of Accelr8 Technology Corp.; and Mark Spiecker, vice president at Sharklet Technology.

Each week Studio 12 explores hot issues and fascinating topics with provocative and knowledgeable guests.  Studio 12 is the only primetime television show in Colorado that encourages viewers at home to call in and join the discussion. 

This episode of Studio 12 also will be available for viewing via the free video-on-demand feature of www.KBDI.org after February 27.